ru 58841 has been researched along with hydroxyflutamide in 1 studies
| Studies (ru 58841) | Trials (ru 58841) | Recent Studies (post-2010) (ru 58841) | Studies (hydroxyflutamide) | Trials (hydroxyflutamide) | Recent Studies (post-2010) (hydroxyflutamide) |
|---|---|---|---|---|---|
| 25 | 0 | 4 | 288 | 5 | 55 |
| Protein | Taxonomy | ru 58841 (IC50) | hydroxyflutamide (IC50) |
|---|---|---|---|
| Progesterone receptor | Homo sapiens (human) | 2.013 | |
| Androgen receptor | Homo sapiens (human) | 0.9313 | |
| Androgen receptor | Mus musculus (house mouse) | 0.6073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Miyamoto, H; Wilding, G; Yeh, S | 1 |
1 other study(ies) available for ru 58841 and hydroxyflutamide
| Article | Year |
|---|---|
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.
Topics: Androgen Antagonists; Androgens; Anilides; Cyproterone Acetate; Drug Interactions; Flutamide; Humans; Imidazoles; Male; Mifepristone; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Binding; Protein Conformation; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured | 1998 |